New drug shortages increased nearly 30% last year to their highest level in almost five years, according to a report released last week by the Senate Homeland Security and Governmental Affairs Committee for a hearing on the issue. The report calls for actions to prioritize approvals for critical drugs in shortage; invest in advanced manufacturing to produce critical drugs domestically; and better monitor supply chain vulnerabilities and anticipate possible shortages, among other recommendations. AHA staff and members were interviewed for the report.

Related News Articles

Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of…
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.“Some of the most…
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and…
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to…
Headline
Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a House version of the Mapping America’s Pharmaceutical Supply Act, legislation…